InsidersTradesSigma
Track the 嘉必优 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 嘉必优 has published 18 reports. Market capitalisation: €1.7bn. The latest transaction was filed on 29 August 2025 (Sale). Among the most active insiders: 易华荣. Every trade is free.
18
Insider Decl.
n/a
Thresholds
€90,097
10 ops.
Buy Volume
€1m
8 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,044 of 28,833 companies
73.3
score / 100
Value78
Quality69
FCF yld7.5%
Earn yld8.6%
EV/EBITDA7.8x
ROE3.1%
Gross mgn48%
Net mgn26%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 August 2025
Declarations18 total
18 of 18 declarations
About 嘉必优
嘉必优 is a healthcare and pharmaceutical company listed on the Shanghai Stock Exchange. It specializes in the development and marketing of pharmaceutical products.